1. Activity of second‐generation ALK inhibitors against crizotinib‐resistant mutants in an NPM‐ALK model compared to EML4‐ALK. (26th February 2015) Authors: Fontana, Diletta; Ceccon, Monica; Gambacorti‐Passerini, Carlo; Mologni, Luca Journal: Cancer medicine Issue: Volume 4:Number 7(2015:Jul.) Page Start: 953 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia. Issue 8 (9th June 2022) Authors: Gambacorti‐Passerini, Carlo; Nicolini, Franck Emmanuel; Larson, Richard A.; Aroldi, Andrea; Fontana, Diletta; Piazza, Rocco; le Coutre, Philipp; Antolini, Laura; Assouline, Sarit Journal: American journal of hematology Issue: Volume 97:Issue 8(2022) Page Start: E296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition. Issue 5 (17th October 2020) Authors: Nucera, Silvia; Fazio, Grazia; Piazza, Rocco; Rigamonti, Silvia; Fontana, Diletta; Gambacorti Passerini, Carlo; Maitz, Silvia; Rovelli, Attilio; Biondi, Andrea; Cazzaniga, Giovauni; Balduzzi, Adriana Journal: HemaSphere Issue: Volume 4:Issue 5(2020) Page Start: e460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID‐19 vaccine: A single‐center prospective observational study (NCT05074706). Issue 4 (30th August 2022) Authors: Bossi, Elisa; Aroldi, Andrea; Borin, Lorenza Maria; Verga, Luisa; Fontana, Diletta; Cocito, Federica; Manghisi, Beatrice; Rindone, Giovanni; Cavalca, Fabrizio; Ripamonti, Alessia; Raggi, Monica; Malandrin, Sergio Maria Ivano; Cavallero, Annalisa; Antolini, Laura; Bonardi, Diego; Piazza, Rocco Gio... Journal: EJHaem Issue: Volume 3:Issue 4(2022) Page Start: 1201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of ETNK1 somatic mutations on phosphoethanolamine synthesis, ROS production and DNA damage. (4th March 2021) Authors: Fontana, Diletta; Gambacorti-Passerini, Carlo; Piazza, Rocco Journal: Molecular & cellular oncology Issue: Volume 8:Number 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia. Issue 6 (6th December 2020) Authors: Fontana, Diletta; Ramazzotti, Daniele; Aroldi, Andrea; Redaelli, Sara; Magistroni, Vera; Pirola, Alessandra; Niro, Antonio; Massimino, Luca; Mastini, Cristina; Brambilla, Virginia; Bombelli, Silvia; Bungaro, Silvia; Morotti, Alessandro; Rea, Delphine; Stagno, Fabio; Martino, Bruno; Campiotti, Leo... Journal: HemaSphere Issue: Volume 4:Issue 6(2020) Page Start: e497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Large-scale analysis of SARS-CoV-2 synonymous mutations reveals the adaptation to the human codon usage during the virus evolution. Issue 1 (24th March 2022) Authors: Ramazzotti, Daniele; Angaroni, Fabrizio; Maspero, Davide; Mauri, Mario; D'Aliberti, Deborah; Fontana, Diletta; Antoniotti, Marco; Elli, Elena Maria; Graudenzi, Alex; Piazza, Rocco Journal: Virus evolution Issue: Volume 8:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK)‐positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy. Issue 12 (3rd September 2020) Authors: Bossi, Elisa; Aroldi, Andrea; Brioschi, Filippo A.; Steidl, Carolina; Baretta, Silvia; Renso, Rossella; Verga, Luisa; Fontana, Diletta; Sharma, Geeta G.; Mologni, Luca; Mussolin, Lara; Piazza, Rocco; Gambacorti‐Passerini, Carlo Journal: American journal of hematology Issue: Volume 95:Issue 12(2020:Dec.) Page Start: E319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. RNA‐seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients. Issue 12 (17th November 2015) Authors: Piazza, Rocco; Cecchetti, Caterina; Pirola, Alessandra; Donandoni, Carla; Fontana, Diletta; Mezzatesta, Caterina; Magistroni, Vera; Bianchi, Benedetta; Borin, Lorenza; Fumagalli, Monica; Gambacorti‐Passerini, Carlo Journal: American journal of hematology Issue: Volume 90:Issue 12(2015:Dec.) Page Start: E227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience. (July 2022) Authors: Steidl, Carolina; Aroldi, Andrea; Mologni, Luca; Crespiatico, Ilaria; Fontana, Diletta; Mastini, Cristina; Fumagalli, Monica; Perfetti, Paola; Borin, Lorenza; Valentini, Claudia; Piazza, Rocco; Gambacorti-Passerini, Carlo Journal: Leukemia research Issue: Volume 118(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗